Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Invested Capital (2016 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Return on Invested Capital for 9 consecutive years, with 0.29% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 91.0% year-over-year to 0.29%, compared with a TTM value of 0.29% through Dec 2025, up 91.0%, and an annual FY2025 reading of 0.38%, up 64.0% over the prior year.
  • Return on Invested Capital was 0.29% for Q4 2025 at Zevra Therapeutics, up from 0.31% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 6.53% in Q3 2022 and bottomed at 1.83% in Q2 2024.
  • Average Return on Invested Capital over 5 years is 0.12%, with a median of 0.58% recorded in 2023.
  • The sharpest move saw Return on Invested Capital tumbled -725bps in 2023, then soared 170bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.07% in 2021, then crashed by -1748bps to 1.1% in 2022, then soared by 34bps to 0.72% in 2023, then tumbled by -66bps to 1.21% in 2024, then surged by 76bps to 0.29% in 2025.
  • Business Quant data shows Return on Invested Capital for ZVRA at 0.29% in Q4 2025, 0.31% in Q3 2025, and 0.13% in Q2 2025.